|
|
Volumn 42, Issue 3, 1997, Pages 257-258
|
|
Diminishing impact of in-lab complications.
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTITHROMBOCYTIC AGENT;
FIBRINOLYTIC AGENT;
CORONARY ARTERY DISEASE;
HUMAN;
NOTE;
STENOSIS, OCCLUSION AND OBSTRUCTION;
THROMBOSIS;
TRANSLUMINAL CORONARY ANGIOPLASTY;
ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY;
CONSTRICTION, PATHOLOGIC;
CORONARY DISEASE;
FIBRINOLYTIC AGENTS;
HUMANS;
PLATELET AGGREGATION INHIBITORS;
THROMBOSIS;
|
|
EID: 0031279644
PISSN: 00986569
EISSN: None
Source Type: Journal
DOI: 10.1002/(SICI)1097-0304(199711)42:3<257::AID-CCD3>3.0.CO;2-B Document Type: Note |
|
Times cited : (1)
|
|
References (0)
|
